<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-molecules-26-00035">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Eucker</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Habbel</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Neumann</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Scholz</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>The multi-tyrosine kinase inhibitor TKI258, alone or in combination with RAD001, is effective for treatment of human leukemia with 
   <italic>BCR-ABL</italic> translocation in vitro
  </article-title>
  <source>Anticancer Res.</source>
  <year>2014</year>
  <volume>34</volume>
  <fpage>4909</fpage>
  <lpage>4914</lpage>
  <?supplied-pmid 25202073?>
  <pub-id pub-id-type="pmid">25202073</pub-id>
 </element-citation>
</ref>
